Glenn H. Snyder
Principal, Lifesciences Strategy
Deloitte Consulting LLP
gsnyder@deloitte.com 415-699-4469
Glenn Snyder is a Principal with Deloitte Consulting, LLP. He leads Deloitte’s
Medical Technology practice. Glenn has been serving the life sciences andhealthcare industry as a consultant since 1989 and has been with Deloitte since
1995, tackling issues and opportunities across the healthcare value chain overthe course of his career, including the payor and provider sectors.
Glenn's expertise is within strategy discipline, specifically having helped clients:
 evolve their business models and solutions through digital transformation
 grow through innovation via acquisition and/or organic initiatives
 navigate changes in the healthcare ecosystem by modifying theirofferings and/or commercial model articulate product economic value and improve market access launch new products
 expand in new/emerging markets
 initiate, manage and terminate commercial alliances
Glenn was the lead-off interview for Bloomberg TV’s 2019 series on Medical
Technology. He has been a frequent presenter/moderator at notableconferences including AdvaMed, APACMed, Medical Alley, Medical Device
Strategic Pricing, and the Analytical and Lifesciences Systems Association.
Glenn has also authored/co-authored many articles and whitepapers, including: “Can medtech start-ups show us where the industry is headed? Insightsfrom MedTech Innovator and industry leaders”, Deloitte Center for HealthSolutions, October 2021
 “Medtech leaders prioritize technology and consumers” (based on asurvey of medtech CEOs), Deloitte Insights, July 2020
 “COVID-19 is prompting Medtech to adapt to a rapidly changing world”,Deloitte blog, April 2020
 “Winning in the future of Medtech”, Deloitte Insights, September 2019
 “‘Coop-etition’ could grow as medtech companies prepare fortransformational innovation”, Deloitte blog, September 2019
 “Solving the Prisoner’s Dilemma: Product Innovation, Solutions-Focused
Business Models Can Help Counter Declining Medtech ROC”, MedTech
Strategist, May 2018








“Out of the valley of death: How can entrepreneurs, corporations, andinvestors reinvigorate early-stage medtech innovation?”,Deloitte/AdvaMed, October 2017
“How MedTech leaders can embrace the IoT and improve the delivery andexperience of health care”, SmartBrief, November 2016
“Mobilizing MedTech for mHealth: Market trends and potentialopportunities”, Deloitte publication, October 2015
“Devices and diseases: How the IoT is transforming MedTech”, Deloitte
publication, September 2015
“The current and future state of companion diagnostics”, Deloitte
publication, March 2015
“Next-generation smart MedTech devices”, Deloitte publication, April 2014
“3D opportunity in medical technology”, Deloitte publication, April 2014
“The Three Rules in medical technology: the transformation of anindustry”, Deloitte publication, December 2013

Glenn holds a Master of Business Administration in Finance and Strategic
Management from the Wharton School of the University of Pennsylvania, aMaster of Science in Engineering from the University of Southern California, anda Bachelor of Science in Engineering from Cal Poly, San Luis Obispo.